INDICATIONS FOR USE: The RECELL® Autologous Cell Harvesting Device is indicated for the treatment of acute thermal burn wounds. The RECELL device is used by an appropriately-licensed healthcare professional at the patient’s point of care to prepare autologous RES® Regenerative Epidermal Suspension for direct application to acute partial-thickness thermal burn wounds in patients 18 years of age and older or application in combination with meshed autografting for acute full-thickness thermal burn wounds in pediatric and adult patients.
RE: BARDA Contract to Advance Development of RECELL® System in Soft Tissue Reconstruction, page-8
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.04 |
Change
-0.040(1.30%) |
Mkt cap ! $212.6M | |||
| Open | High | Low | Value | Volume |
| $3.08 | $3.08 | $3.00 | $197.4K | 65.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5353 | $3.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.04 | 479 | 1 |
View Market Depth
| Last trade - 15.16pm 27/09/2024 (20 minute delay) ? |
| AVH (ASX) Chart |